Time for QZyme

BD Biosciences-Clontech of Palo Alto, Calif., http://www.clontech.com has harnessed the power of a DNAzyme, the DNA equivalent of a ribozyme, in its new BD QZyme™ assay for quantitative PCR. The sensitive system, which can detect fewer than 10 copies of a target, can be used with any real-time thermocycler and works via a simple amplification and cleavage reaction.Appended to the gene-specific 5' PCR primer is the inactive antisense strand of a phosphodiesterase DNAzyme. As double-stranded

Written byAparna Sreenivasan
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

BD Biosciences-Clontech of Palo Alto, Calif., http://www.clontech.com has harnessed the power of a DNAzyme, the DNA equivalent of a ribozyme, in its new BD QZymeassay for quantitative PCR. The sensitive system, which can detect fewer than 10 copies of a target, can be used with any real-time thermocycler and works via a simple amplification and cleavage reaction.

Appended to the gene-specific 5' PCR primer is the inactive antisense strand of a phosphodiesterase DNAzyme. As double-stranded copies of the DNA target are produced the active, DNAzyme molecule binds and cleaves a previously dormant substrate, releasing a fluorescent signal that increases in proportion to the amount of amplified DNA. To measure more than one gene at the same time, researchers can use two different DNAzymes with unique spectral signals.

So far, beta testers "like the robustness of the system," says Abe Couse, senior product manager. Slated for an early 2004 release, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies